Meeting
2022 ASCO Quality Care Symposium
Evaluation of a virtual, nurse practitioner–led, pre-counselling seminar for mainstream germline genetic testing using a patient-reported outcomes measure (PROM).
Authors
Jennifer Marie Rauw
BC Cancer Agency, Victoria, BC, Canada
Jennifer Marie Rauw, Laurie Barnhardt, Heather Lockyer
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A
Track
Cost, Value, and Policy,Health Care Access, Equity, and Disparities,Patient Experience
Sub Track
Provider Impact on Quality From the Patient Perspective
Citation
J Clin Oncol 40, 2022 (suppl 28; abstr 290)
DOI
10.1200/JCO.2022.40.28_suppl.290
Abstract #
290
Poster Bd #
G29
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Using patient-reported outcomes to assess the impact of germline genetic testing on prostate cancer patients.
First Author: Sarah M. Nielsen
Poster
2021 ASCO Quality Care Symposium
Assessing comprehensive care deficits in United States (U.S.) ovarian cancer programs to inform quality improvement initiatives.
First Author: Matthew Smeltzer
Poster
2018 ASCO Annual Meeting
Evaluating empowerment in genetic counseling using patient reported outcomes.
First Author: Suat Ying Lee
Poster
2024 ASCO Annual Meeting
Genetic counseling and subsequent cascade genetic testing for women with a family history of pathogenic BRCA1 mutation: A cost-effectiveness model.
First Author: Allison Walker